HMGCS2 and metabolic dysfunction-associated steatohepatitis: To explore whether impaired ketogenesis in NASH with T2DM stems from dysregulated HMGCS2, C57BL/6J mice were treated with CDAHFD and STZ for 8 weeks to establish a NASH combined with T2DM model.